Tel Aviv-based Pecan AI, which offers a predictive analytics service for enterprises, raises a $66M Series C, bringing its total funding to $117.5M
Kyle Wiggers / VentureBeat :
Context & Ripple Effects
Pecan AI's Series C more than doubles what it had on hand after its $35M Series B led by GGV Capital in May 2021, taking total raised from roughly $50M to $117.5M in under a year — a fast step-up for an enterprise no-code predictive analytics platform.
The round lands inside a visibly concentrated Tel Aviv funding pattern: NeuroBlade raised an $83M Series B for data analytics hardware months earlier, Weka later pulled a $135M Series D for AI data management, and Voyantis — which predicts customer lifetime value for marketers — went from a $19M seed to a $41M raise across the same window.
First-order effects
- Pecan AI now has the balance sheet to push its no-code predictive modeling service deeper into enterprise accounts, competing directly for the marketing-prediction budgets that Voyantis' lifetime-value forecasting targets.
Second-order effects
- Tel Aviv's predictive-analytics and data-infrastructure startups — Pecan, Voyantis, NeuroBlade, Weka — are bidding against each other for the same enterprise data teams and engineering talent, pushing up hiring costs across the cluster even as each raises larger rounds.
Third-order effects
- If the cadence holds, enterprise predictive analytics consolidates around capitalized no-code platforms rather than bespoke data-science consultancies, with Israel's ecosystem structuring itself as the supply base for that shift alongside its generative-AI players like AI21.
The trend: Tel Aviv is emerging as a repeat funder of applied predictive-AI companies, with successive nine-figure rounds flowing to firms that package machine learning for enterprise buyers without requiring in-house data science.